Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

SHPH Shuttle Pharmaceuticals Holdings Inc

0,7601

0,0091 (1,21%)

31 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Both Shuttle Pharmaceuticals (Nasdaq:SHPH) and Northwest Biotherapeutics

To read the full story on AllPennyStocks.com, click here.

Shuttle Pharmaceuticals (NASDAQ:SHPH)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Shuttle Pharmaceuticals Charts.

Shuttle Pharmaceuticals (NASDAQ:SHPH)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Shuttle Pharmaceuticals Charts.

News Shuttle Pharmaceuticals Holdings Inc

Form 8-K - Current report
Dienstag 28 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 24 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 21 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Dienstag 21 Januar 2025 (1 Woche vor) • GlobeNewswire Inc.

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments
Montag 13 Januar 2025 (3 Wochen vor) • AllPennyStocks.com

Form 8-K - Current report
Dienstag 7 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Dienstag 7 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 19 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
Donnerstag 19 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 26 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
Dienstag 26 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 13 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Shuttle Pharmaceuticals Holdings Inc News-Artikel

Brisanet Participacoes ON

Royal Caribbean

BNP Paribas Issuance

Societe Generale Effekten

BNP Paribas Issuance

Societe Generale Effekten

BNP Paribas Issuance BV

Leonteq Securities

Solactive X5 Daily

Rreef Fondimmobiliari Sgr

Conservative Balanced Wo...

Exchange Traded

L&G Artificial Intellige...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen